Australia markets close in 4 hours 34 minutes

RAPT Therapeutics, Inc. (RAPT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.0800-0.1600 (-4.94%)
At close: 04:00PM EDT
3.2000 +0.12 (+3.90%)
After hours: 07:57PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
2,283
0
1,527
3,813
5,042
-
Operating expenses
Research development
61,927
101,002
67,082
56,985
45,485
-
Selling general and administrative
19,754
26,060
20,240
16,037
12,771
-
Total operating expenses
81,681
127,062
87,322
73,022
58,256
-
Operating income or loss
-79,398
-127,062
-85,795
-69,209
-53,214
-
Total other income/expenses net
582
10,264
1,957
5
1,312
-
Income before tax
-78,816
-116,798
-83,838
-69,204
-51,902
-
Income tax expense
-
-
-
0
990
660
Income from continuing operations
-78,816
-116,798
-83,838
-69,204
-52,892
-
Net income
-78,816
-116,798
-83,838
-69,204
-52,892
-
Net income available to common shareholders
-78,816
-116,798
-83,838
-69,204
-52,892
-
Basic EPS
-2.89
-
-2.58
-2.53
-2.19
-9.89
Diluted EPS
-2.89
-
-2.58
-2.53
-2.19
-9.89
Basic average shares
37,671
-
32,540
27,390
24,134
4,346
Diluted average shares
37,671
-
32,540
27,390
24,134
4,346